The researchers say their study shows a vaginal gel substance reduced the risk of HIV infection among women who used it.
VOA: special.2010.07.21
The gel contains tenofovir. This is a common anti-retroviral drug used to treat people with HIV, the virus that causes AIDS.
VOA: special.2010.07.21
A new study in the journal Nature has shown some hopeful results from an experimental gel that might protect women from H.I.V.
VOA: special.2009.03.16
Women who used the gel more than eighty percent of the times when they had sex had fifty-four percent fewer HIV infections.
VOA: special.2010.07.21
And the study found that the women who used the gel more often had even better results.
VOA: special.2010.07.21
Health experts say the results of the study show that tenofovir gel can empower women.
VOA: special.2010.07.21
Women who used the tenofovir gel reduced their risk of HIV infection by thirty-nine percent.
VOA: special.2010.07.21
However,researchers say they will study why the gel did not protect in all cases.
VOA: special.2010.07.21
Some scientists say the amount of tenofovir in the gel may be too low.
VOA: special.2010.07.21
The scientists say the tenofovir gel was also effective against another sexually spread disease.
VOA: special.2010.07.21
The gel reduced the rate of infection of herpes simplex-two by fifty-one percent.
VOA: special.2010.07.21
More studies are needed to know if the gel could work for humans.
VOA: special.2009.03.16
The other half were given a gel without an active substance.
VOA: special.2010.07.21
Half were given the gel containing tenofovir.
VOA: special.2010.07.21
The gel is made from glycerol monolaurate.
VOA: special.2009.03.16
Other people saying the treatment programs that have been scaled-up over the last number of years have been the best investments in building health systems, while also dealing with the AIDS epidemic, One of the major announcements expected at the 18th International AIDS conference is about a microbicide gel called CAPRISA 004.
VOA: standard.2010.07.15
应用推荐